Araştırma Makalesi
BibTex RIS Kaynak Göster

RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki

Yıl 2024, Cilt: 14 Sayı: 3, 152 - 159, 15.09.2024

Öz

ABSTRACT
Objective: Developing contrast induced nephropathy after primary PCI in patients with ST segment elevation
myocardial infarction is a risky condition in terms of mortality and morbidity. Various studies have shown
that the systemic inflammatory index predicts (SII) the development of CIN. Mean platelet volume (MPV)
is an important indicator known to be associated with the platelet function and activation. Therefore, we
revised SII and named it modified SII (mSII) by using NLR multiply MPV.
Material and Methods: This study includes patients who underwent pPCI due to STEMI in our cardiology
department between February 2015 and February 2021. Modified SII was obtained by using MPV instead
of platelet in the formula (mSII= NLR x MPV). Patients who underwent pPCI with STEMI were divided into
two groups, those with CIN and those without CIN, and compared. Informed consent was obtained from
all patients.
Results: In the logistic regression analysis, it was observed that the mSII, NLR, GFR and contrast medium
amount was independent predictor of CIN. The optimal threshold mSII for predicting CIN was >42.5, with a
78.1% sensitivity and 52.3% specificity ([AUC]: 0.639, 95%CI: 0.602- 0.674, p< 0.001). Pairwise comparison
of ROC curves, it was observed that the predictive value of mSII for the development of CIN was better than
NLR. (z-test = 3.144, P = 0.001)
Conclusion: We think that mSII, which we have shown to be superior to SII in predicting the development
of CIN and is very easy to calculate, is a parameter that can be considered in predicting the development of
CIN after pPCI in STEMI patients.

Kaynakça

  • 1. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993; 329: 1615–22.
  • 2. Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv. 2005; 64:442-8.
  • 3. Shaker OG, El-Shehaby A, El-Khatib M. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology. 2010; 61: 731-6.
  • 4. Mehran R, Aymong ED, Nikolsky E, Zoran L, Loannis L, Martin F, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44: 1393-9.
  • 5. Senoo T, Motohiro M, Kamihata H, Yamamoto S, Isonon T, Manabe K, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2010. 1;105(5):624-8.
  • 6. Marenzi G, Lauri G, Assanelli E, Campodonico J, Metrio M, Marana I, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004; 44: 1780-5.
  • 7. McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103: 368-75
  • 8. Kwasa EA, Vinayak S, Armstrong R. The role of inflammationin contrast-induced nephropathy. Br J Radiol. 2014; 87: 20130738.
  • 9. Bağcı A, Aksoy F, Baş H A. Systemic Immune-Inflammation Index May Predict the Development of Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Angiology 2021; 73: 218-24
  • 10. Slavka G, Perkmann T, Haslacher H, Greisenegger S, Marsik C, Wagner O F, et al. Mean Platelet Volume May Represent a Predictive Parameter for Overall Vascular Mortality and Ischemic Heart Disease". Arteriosclerosis, Thrombosis, and Vascular Biology. 2011;
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Kardiyoloji
Bölüm Orjinal Çalışma
Yazarlar

Levent Özdemir

Adil Bayramoğlu

Yayımlanma Tarihi 15 Eylül 2024
Gönderilme Tarihi 1 Eylül 2024
Kabul Tarihi 13 Eylül 2024
Yayımlandığı Sayı Yıl 2024 Cilt: 14 Sayı: 3

Kaynak Göster

APA Özdemir, L., & Bayramoğlu, A. (2024). RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki. Bozok Tıp Dergisi, 14(3), 152-159.
AMA Özdemir L, Bayramoğlu A. RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki. Bozok Tıp Dergisi. Eylül 2024;14(3):152-159.
Chicago Özdemir, Levent, ve Adil Bayramoğlu. “RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi Ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki”. Bozok Tıp Dergisi 14, sy. 3 (Eylül 2024): 152-59.
EndNote Özdemir L, Bayramoğlu A (01 Eylül 2024) RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki. Bozok Tıp Dergisi 14 3 152–159.
IEEE L. Özdemir ve A. Bayramoğlu, “RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki”, Bozok Tıp Dergisi, c. 14, sy. 3, ss. 152–159, 2024.
ISNAD Özdemir, Levent - Bayramoğlu, Adil. “RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi Ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki”. Bozok Tıp Dergisi 14/3 (Eylül 2024), 152-159.
JAMA Özdemir L, Bayramoğlu A. RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki. Bozok Tıp Dergisi. 2024;14:152–159.
MLA Özdemir, Levent ve Adil Bayramoğlu. “RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi Ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki”. Bozok Tıp Dergisi, c. 14, sy. 3, 2024, ss. 152-9.
Vancouver Özdemir L, Bayramoğlu A. RELATIONSHIP BETWEEN MODIFIED SYSTEMIC IMMUNE-INFLAMMATION INDEX AND CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ST Segment Yükselmeli Miyokard İnfarktüsü Olan Hastalarda Modifiye Sistemik İmmün İnflamasyon İndeksi ile Kontrastın Neden Olduğu Nefropati Arasındaki İlişki. Bozok Tıp Dergisi. 2024;14(3):152-9.
Copyright © BOZOK Üniversitesi - Tıp Fakültesi